To evaluate the performance of PTeye™ and FLUOBEAM® LX in identifying parathyroid adenomas during parathyroidectomy.
Key Findings:
PTeye™ identified all parathyroid adenomas (100%), while FLUOBEAM® LX failed to identify 15% of cases, indicating a significant difference in performance.
PTeye™ confirmed adenoma existence in under 1 minute for 65% of cases, while FLUOBEAM® LX had slower identification times, highlighting the efficiency of PTeye™.
Interpretation:
The study supports the use of NIRAF technology for intraoperative identification of parathyroid adenomas, with probe-based systems like PTeye™ showing advantages in speed and accuracy over camera-based systems, which may enhance surgical outcomes.
Limitations:
Small sample size of 40 patients.
Lack of true negative data for calculating specificity and other predictive values.
Conclusion:
Probe-based systems like PTeye™ may enhance parathyroid adenoma identification, particularly beneficial for non-specialized surgeons and in recurrent cases.
Researchers at Florida International University (FIU), working in collaboration with Baptist Health South Florida, are combining a digital stethoscope with artificial intelligence (AI) and advanced sound analysis to better detect subtle signs of heart disease long before symptoms appear.
